POTASSIUM PHOSPHATES
- Product NDC
- 65145-194
- 11-digit product format
- 651450194
- Labeler code
- 65145
- Product ID
- 65145-194_e6c7b072-db35-42c2-9bc2-d25cd20ca8b0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- POTASSIUM PHOSPHATES
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Labeler
- Caplin Steriles Limited
- Application
- ANDA220373
- Marketing category
- ANDA
- Marketing start
- 2026-09-17
- Substance
- POTASSIUM PHOSPHATE, MONOBASIC; POTASSIUM PHOSPHATE, DIBASIC
- Active strength
- 224; 236 mg/mL; mg/mL
- Pharmacologic classes
- Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A220373-001 | POTASSIUM PHOSPHATES | POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC | 1.18GM/5ML (236MG/ML);1.12GM/5ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-03-12 | |
| A220373-002 | POTASSIUM PHOSPHATES | POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC | 3.54GM/15ML (236MG/ML);3.36GM/15ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-03-12 | |
| A220373-003 | POTASSIUM PHOSPHATES | POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC | 11.8GM/50ML (236MG/ML);11.2GM/50ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-03-12 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A220373-001 | AP |
| A220373-002 | AP |
| A220373-003 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A220373-001 | POTASSIUM PHOSPHATES | 1.18GM/5ML (236MG/ML);1.12GM/5ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-03-12 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A220373-002 | POTASSIUM PHOSPHATES | 3.54GM/15ML (236MG/ML);3.36GM/15ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-03-12 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A220373-003 | POTASSIUM PHOSPHATES | 11.8GM/50ML (236MG/ML);11.2GM/50ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-03-12 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A220373-001 | POTASSIUM PHOSPHATES | 1.18GM/5ML (236MG/ML);1.12GM/5ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-03-12 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A220373-002 | POTASSIUM PHOSPHATES | 3.54GM/15ML (236MG/ML);3.36GM/15ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-03-12 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A220373-003 | POTASSIUM PHOSPHATES | 11.8GM/50ML (236MG/ML);11.2GM/50ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-03-12 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220373-001 | POTASSIUM PHOSPHATES | 1.18GM/5ML (236MG/ML);1.12GM/5ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-03-12 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220373-002 | POTASSIUM PHOSPHATES | 3.54GM/15ML (236MG/ML);3.36GM/15ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-03-12 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220373-003 | POTASSIUM PHOSPHATES | 11.8GM/50ML (236MG/ML);11.2GM/50ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-03-12 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A220373-001 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A220373-002 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A220373-003 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A220373-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A220373-002 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A220373-003 | AP | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220373-001 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220373-002 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220373-003 | AP | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- POTASSIUM PHOSPHATES
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| POTASSIUM PHOSPHATE, MONOBASIC | 224 mg/mL |
| POTASSIUM PHOSPHATE, DIBASIC | 236 mg/mL |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 65145-194-01 | POTASSIUM PHOSPHATES | 5 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION, CONCENTRATE | 5 | 1 | |
| 65145-194-25 | POTASSIUM PHOSPHATES | 25 in 1 CARTON | INJECTION, SOLUTION, CONCENTRATE | 25 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| POTASSIUM PHOSPHATES | POTASSIUM PHOSPHATES | GLENMARK PHARMACEUTICALS INC., USA | 70c7710c-a354-4941-bd46-e64d6ea6b5dc | 2026-03-20 | Warnings, Adverse reactions | 220373 ANDA220373 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1928567 | potassium phosphates (phosphorus 15 MMOL / potassium 22 MEQ) in 5 ML Injection | PSN | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 2667657 | potassium phosphates (phosphorus 3 MMOL / potassium 4.4 MEQ) in 1 ML Injectable Solution | PSN | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 1928569 | potassium phosphates (phosphorus 45 MMOL / potassium 66 MEQ) in 15 ML Injection | PSN | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 1928569 | 15 ML dibasic potassium phosphate 236 MG/ML / monobasic potassium phosphate 224 MG/ML Injection | SCD | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 1928567 | 5 ML dibasic potassium phosphate 236 MG/ML / monobasic potassium phosphate 224 MG/ML Injection | SCD | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 2667657 | dibasic potassium phosphate 236 MG/ML / monobasic potassium phosphate 224 MG/ML Injectable Solution | SCD | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 1928569 | 15 ML Dibasic K+ phosphate 236 MG/ML / Monobasic K+ phosphate 224 MG/ML Injection | SY | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 1928569 | 15 ML Dibasic Pot phosphate 236 MG/ML / Monobasic Pot phosphate 224 MG/ML Injection | SY | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 1928567 | 5 ML Dibasic K+ phosphate 236 MG/ML / Monobasic K+ phosphate 224 MG/ML Injection | SY | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 1928567 | 5 ML Dibasic Pot phosphate 236 MG/ML / Monobasic Pot phosphate 224 MG/ML Injection | SY | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 2667657 | dibasic K+ phosphate 236 MG/ML / monobasic K+ phosphate 224 MG/ML Injectable Solution | SY | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 2667657 | dibasic Pot phosphate 236 MG/ML / monobasic Pot phosphate 224 MG/ML Injectable Solution | SY | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 1928567 | phosphorus 15 MMOL / potassium 22 MEQ per 5 ML Injection | SY | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 2667657 | phosphorus 3 MMOL / potassium 4.4 MEQ per 1 ML Injectable Solution | SY | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 1928569 | phosphorus 45 MMOL / potassium 66 MEQ per 15 ML Injection | SY | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 1928567 | potassium phosphates (phosphorus 15 MMOL / potassium 22 MEQ) per 5 ML Injection | SY | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 1928569 | potassium phosphates (phosphorus 45 MMOL / potassium 66 MEQ) per 15 ML Injection | SY | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1928567 | potassium phosphates (phosphorus 15 MMOL / potassium 22 MEQ) in 5 ML Injection | PSN | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 2667657 | potassium phosphates (phosphorus 3 MMOL / potassium 4.4 MEQ) in 1 ML Injectable Solution | PSN | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 1928569 | potassium phosphates (phosphorus 45 MMOL / potassium 66 MEQ) in 15 ML Injection | PSN | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 1928569 | 15 ML dibasic potassium phosphate 236 MG/ML / monobasic potassium phosphate 224 MG/ML Injection | SCD | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 1928567 | 5 ML dibasic potassium phosphate 236 MG/ML / monobasic potassium phosphate 224 MG/ML Injection | SCD | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 2667657 | dibasic potassium phosphate 236 MG/ML / monobasic potassium phosphate 224 MG/ML Injectable Solution | SCD | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 1928569 | 15 ML Dibasic K+ phosphate 236 MG/ML / Monobasic K+ phosphate 224 MG/ML Injection | SY | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 1928569 | 15 ML Dibasic Pot phosphate 236 MG/ML / Monobasic Pot phosphate 224 MG/ML Injection | SY | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 1928567 | 5 ML Dibasic K+ phosphate 236 MG/ML / Monobasic K+ phosphate 224 MG/ML Injection | SY | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 1928567 | 5 ML Dibasic Pot phosphate 236 MG/ML / Monobasic Pot phosphate 224 MG/ML Injection | SY | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 2667657 | dibasic K+ phosphate 236 MG/ML / monobasic K+ phosphate 224 MG/ML Injectable Solution | SY | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 2667657 | dibasic Pot phosphate 236 MG/ML / monobasic Pot phosphate 224 MG/ML Injectable Solution | SY | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 1928567 | phosphorus 15 MMOL / potassium 22 MEQ per 5 ML Injection | SY | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 2667657 | phosphorus 3 MMOL / potassium 4.4 MEQ per 1 ML Injectable Solution | SY | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 1928569 | phosphorus 45 MMOL / potassium 66 MEQ per 15 ML Injection | SY | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 1928567 | potassium phosphates (phosphorus 15 MMOL / potassium 22 MEQ) per 5 ML Injection | SY | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
| 1928569 | potassium phosphates (phosphorus 45 MMOL / potassium 66 MEQ) per 15 ML Injection | SY | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 65145-194-01 | 65145019401 | 5 mL in 1 VIAL, SINGLE-DOSE | 5 ml | Historical | |||
| 65145-194-25 | 65145019425 | 25 VIAL, SINGLE-DOSE in 1 CARTON (65145-194-25) / 5 mL in 1 VIAL, SINGLE-DOSE (65145-194-01) | 2026-09-17 | No | No | Current |